HFM
GMAB icon

Harvest Fund Management’s Genmab GMAB Stock Holding History

Harvest Fund Management’s Portfolio GMAB Stock Details GMAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-166
Closed -$6K – 661
2023
Q3 		$6K Hold
166
– – ﹤0.01% 563
2023
Q2 		$6K Hold
166
– – ﹤0.01% 594
2023
Q1 		$6K Hold
166
– – ﹤0.01% 677
2022
Q4 		$6K Buy
+166
New +$6.84K ﹤0.01% 692

Other funds holding GMAB

AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
HL
Harding Loevner Bridgewater, New Jersey $9.72B AUM 22.38% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Harvest Fund Management's GMAB Position: Q4 2023 in Review

Harvest Fund Management sold out of Genmab (GMAB) in Q4 2023, closing a stake of 166 shares — an estimated $6K sold.

Harvest Fund Management first reported a position in GMAB in Q4 2022 and held it in 4 quarters. The position peaked at $6K in Q3 2023. 225 funds tracked by Wall St. Rank hold GMAB as of Q4 2023.

  • Harvest Fund Management reported no remaining Genmab position as of Q4 2023 after selling out during the quarter.
  • Harvest Fund Management sold 166 Genmab shares in Q4 2023, an estimated $6K.
  • Harvest Fund Management first reported a position in Genmab in Q4 2022 and held it in 4 quarters.
  • Harvest Fund Management's Genmab position peaked at $6K in Q3 2023.
  • 225 funds tracked by Wall St. Rank held Genmab as of Q4 2023.

Based on Harvest Fund Management's 13F filing for Q4 2023, filed 2 Feb 2024.